IL17A and prostate carcinoma: Excluding broad-spectrum pathways such as the pathways in cancer, the results showed that prostate cancer, endocrine resistance, lipids and atherosclerosis, bladder cancer, and the IL-17 signaling pathway function in the regulation of the main components of Pule’an Tablets, which can provide reference for the subsequent study of the pharmacodynamic mechanism.